Postexposure protection of macaques from vaginal SHIV infection by topical integrase inhibitors (Q42232018)

19 October 2017

Postexposure protection of macaques from vaginal SHIV infection by topical integrase inhibitors (English)

1 reference

19 October 2017

14

Walid Heneine

1 reference

19 October 2017

Charles Dobard

1

1 reference

19 October 2017

Sunita Sharma

2

1 reference

19 October 2017

Urvi M Parikh

3

1 reference

19 October 2017

Rolieria West

4

1 reference

19 October 2017

Andrew Taylor

5

1 reference

19 October 2017

Amy Martin

6

1 reference

19 October 2017

Chou-Pong Pau

7

1 reference

19 October 2017

Debra L Hanson

8

1 reference

19 October 2017

Jonathan Lipscomb

9

1 reference

19 October 2017

James Smith

10

1 reference

19 October 2017

Francis Novembre

11

1 reference

19 October 2017

Daria Hazuda

12

1 reference

19 October 2017

J Gerardo Garcia-Lerma

13

1 reference

19 October 2017

language of work or name

English

0 references

publication date

1 March 2014

1 reference

Science Translational Medicine

19 October 2017

1 reference

19 October 2017

6

1 reference

19 October 2017

227

1 reference

19 October 2017

227ra35

1 reference

Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women

19 October 2017

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3007701

Preexposure prophylaxis for HIV infection among African women

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3007701

Safety and efficacy of tenofovir/IQP-0528 combination gels - a dual compartment microbicide for HIV-1 prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3007701

Complete protection from repeated vaginal simian-human immunodeficiency virus exposures in macaques by a topical gel containing tenofovir alone or with emtricitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3007701

Protection of rhesus macaques from vaginal infection by vaginally delivered maraviroc, an inhibitor of HIV-1 entry via the CCR5 co-receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3007701

A single dose of a MIV-150/Zinc acetate gel provides 24 h of protection against vaginal simian human immunodeficiency virus reverse transcriptase infection, with more limited protection rectally 8-24 h after gel use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3007701

Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3007701

Durable protection from vaginal simian-human immunodeficiency virus infection in macaques by tenofovir gel and its relationship to drug levels in tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3007701

The use of a new in vitro reaction substrate reproducing both U3 and U5 regions of the HIV-1 3'-ends increases the correlation between the in vitro and in vivo effects of the HIV-1 integrase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3007701

New first and second generation inhibitors of human immunodeficiency virus-1 integrase

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3007701

Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3007701

Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3007701

Virological evidence supporting the use of raltegravir in HIV post-exposure prophylaxis regimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3007701

Diketo acid inhibitor mechanism and HIV-1 integrase: implications for metal binding in the active site of phosphotransferase enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3007701

Dolutegravir (S/GSK1349572) exhibits significantly slower dissociation than raltegravir and elvitegravir from wild-type and integrase inhibitor-resistant HIV-1 integrase-DNA complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3007701

Stage-dependent inhibition of HIV-1 replication by antiretroviral drugs in cell culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3007701

Hormonal synchronization of the menstrual cycles of pigtail macaques to facilitate biomedical research including modeling HIV susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3007701

Brief but efficient: acute HIV infection and the sexual transmission of HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3007701

High susceptibility to repeated, low-dose, vaginal SHIV exposure late in the luteal phase of the menstrual cycle of pigtail macaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3007701

Cyclic changes in the vaginal epithelium of normal rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3007701

Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3007701

Genital ulcers facilitate rapid viral entry and dissemination following intravaginal inoculation with cell-associated simian immunodeficiency virus SIVmac239.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3007701

The LEDGF/p75 integrase interaction, a novel target for anti-HIV therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3007701

Mucus as a barrier to lipophilic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3007701

Intravaginal ring eluting tenofovir disoproxil fumarate completely protects macaques from multiple vaginal simian-HIV challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3007701

Next-generation integrase inhibitors : where to after raltegravir?

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3007701

New Class of HIV-1 Integrase (IN) Inhibitors with a Dual Mode of Action

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3007701

Multiple vaginal exposures to low doses of R5 simian-human immunodeficiency virus: strategy to study HIV preclinical interventions in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3007701

Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3007701

Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3007701

10.1126/SCITRANSLMED.3007701

21 January 2018

Identifiers

DOI

1 reference

19 October 2017

1 reference